1
|
Toner YC, Prévot G, van Leent MMT, Munitz J, Oosterwijk R, Verschuur AVD, van Elsas Y, Peric V, Maas RJF, Ranzenigo A, Morla-Folch J, Wang W, Umali M, de Dreu A, Fernandes JC, Sullivan NAT, Maier A, Mason C, Reiner T, Fayad ZA, Mulder WJM, Teunissen AJP, Pérez-Medina C. Macrophage PET imaging in mouse models of cardiovascular disease and cancer with an apolipoprotein-inspired radiotracer. Npj Imaging 2024; 2:12. [PMID: 38765879 PMCID: PMC11096117 DOI: 10.1038/s44303-024-00009-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 02/06/2024] [Indexed: 05/22/2024]
Abstract
Macrophages are key inflammatory mediators in many pathological conditions, including cardiovascular disease (CVD) and cancer, the leading causes of morbidity and mortality worldwide. This makes macrophage burden a valuable diagnostic marker and several strategies to monitor these cells have been reported. However, such strategies are often high-priced, non-specific, invasive, and/or not quantitative. Here, we developed a positron emission tomography (PET) radiotracer based on apolipoprotein A1 (ApoA1), the main protein component of high-density lipoprotein (HDL), which has an inherent affinity for macrophages. We radiolabeled an ApoA1-mimetic peptide (mA1) with zirconium-89 (89Zr) to generate a lipoprotein-avid PET probe (89Zr-mA1). We first characterized 89Zr-mA1's affinity for lipoproteins in vitro by size exclusion chromatography. To study 89Zr-mA1's in vivo behavior and interaction with endogenous lipoproteins, we performed extensive studies in wildtype C57BL/6 and Apoe-/- hypercholesterolemic mice. Subsequently, we used in vivo PET imaging to study macrophages in melanoma and myocardial infarction using mouse models. The tracer's cell specificity was assessed by histology and mass cytometry (CyTOF). Our data show that 89Zr-mA1 associates with lipoproteins in vitro. This is in line with our in vivo experiments, in which we observed longer 89Zr-mA1 circulation times in hypercholesterolemic mice compared to C57BL/6 controls. 89Zr-mA1 displayed a tissue distribution profile similar to ApoA1 and HDL, with high kidney and liver uptake as well as substantial signal in the bone marrow and spleen. The tracer also accumulated in tumors of melanoma-bearing mice and in the ischemic myocardium of infarcted animals. In these sites, CyTOF analyses revealed that natZr-mA1 was predominantly taken up by macrophages. Our results demonstrate that 89Zr-mA1 associates with lipoproteins and hence accumulates in macrophages in vivo. 89Zr-mA1's high uptake in these cells makes it a promising radiotracer for non-invasively and quantitatively studying conditions characterized by marked changes in macrophage burden.
Collapse
Affiliation(s)
- Yohana C. Toner
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Geoffrey Prévot
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Mandy M. T. van Leent
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Jazz Munitz
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Roderick Oosterwijk
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
| | - Anna Vera D. Verschuur
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Yuri van Elsas
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Vedran Peric
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
| | - Rianne J. F. Maas
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Anna Ranzenigo
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Judit Morla-Folch
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - William Wang
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Martin Umali
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Anne de Dreu
- Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
| | - Jessica Chimene Fernandes
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Nathaniel A. T. Sullivan
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Alexander Maier
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Cardiology and Angiology, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany
| | - Christian Mason
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY USA
| | - Thomas Reiner
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY USA
- Department of Radiology, Weill Cornell Medical College, New York, NY USA
- Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY USA
| | - Zahi A. Fayad
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Willem J. M. Mulder
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
- Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
| | - Abraham J. P. Teunissen
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
| | - Carlos Pérez-Medina
- BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
- Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
| |
Collapse
|
2
|
Morla-Folch J, Ranzenigo A, Fayad ZA, Teunissen AJP. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions. Small 2024; 20:e2307502. [PMID: 38050951 PMCID: PMC11045328 DOI: 10.1002/smll.202307502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Revised: 10/30/2023] [Indexed: 12/07/2023]
Abstract
Nanomaterials have revolutionized medicine by enabling control over drugs' pharmacokinetics, biodistribution, and biocompatibility. However, most nanotherapeutic batches are highly heterogeneous, meaning they comprise nanoparticles that vary in size, shape, charge, composition, and ligand functionalization. Similarly, individual nanotherapeutics often have heterogeneously distributed components, ligands, and charges. This review discusses nanotherapeutic heterogeneity's sources and effects on experimental readouts and therapeutic efficacy. Among other topics, it demonstrates that heterogeneity exists in nearly all nanotherapeutic types, examines how nanotherapeutic heterogeneity arises, and discusses how heterogeneity impacts nanomaterials' in vitro and in vivo behavior. How nanotherapeutic heterogeneity skews experimental readouts and complicates their optimization and clinical translation is also shown. Lastly, strategies for limiting nanotherapeutic heterogeneity are reviewed and recommendations for developing more reproducible and effective nanotherapeutics provided.
Collapse
Affiliation(s)
- Judit Morla-Folch
- Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, 10029, NY, USA
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA
| | - Anna Ranzenigo
- Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, 10029, NY, USA
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA
| | - Zahi Adel Fayad
- Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, 10029, NY, USA
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA
| | - Abraham Jozef Petrus Teunissen
- Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, 10029, NY, USA
- Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA
- Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA
| |
Collapse
|
3
|
Rother N, Yanginlar C, Prévot G, Jonkman I, Jacobs M, van Leent MMT, van Heck J, Matzaraki V, Azzun A, Morla-Folch J, Ranzenigo A, Wang W, van der Meel R, Fayad ZA, Riksen NP, Hilbrands LB, Lindeboom RGH, Martens JHA, Vermeulen M, Joosten LAB, Netea MG, Mulder WJM, van der Vlag J, Teunissen AJP, Duivenvoorden R. Acid ceramidase regulates innate immune memory. Cell Rep 2023; 42:113458. [PMID: 37995184 DOI: 10.1016/j.celrep.2023.113458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Revised: 09/04/2023] [Accepted: 11/02/2023] [Indexed: 11/25/2023] Open
Abstract
Innate immune memory, also called "trained immunity," is a functional state of myeloid cells enabling enhanced immune responses. This phenomenon is important for host defense, but also plays a role in various immune-mediated conditions. We show that exogenously administered sphingolipids and inhibition of sphingolipid metabolizing enzymes modulate trained immunity. In particular, we reveal that acid ceramidase, an enzyme that converts ceramide to sphingosine, is a potent regulator of trained immunity. We show that acid ceramidase regulates the transcription of histone-modifying enzymes, resulting in profound changes in histone 3 lysine 27 acetylation and histone 3 lysine 4 trimethylation. We confirm our findings by identifying single-nucleotide polymorphisms in the region of ASAH1, the gene encoding acid ceramidase, that are associated with the trained immunity cytokine response. Our findings reveal an immunomodulatory effect of sphingolipids and identify acid ceramidase as a relevant therapeutic target to modulate trained immunity responses in innate immune-driven disorders.
Collapse
Affiliation(s)
- Nils Rother
- Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Cansu Yanginlar
- Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Geoffrey Prévot
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Inge Jonkman
- Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Maaike Jacobs
- Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Mandy M T van Leent
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medical Biochemistry, Amsterdam University Medical Centers, Amsterdam, the Netherlands
| | - Julia van Heck
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Vasiliki Matzaraki
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Anthony Azzun
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Judit Morla-Folch
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Anna Ranzenigo
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - William Wang
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Roy van der Meel
- Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands
| | - Zahi A Fayad
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Niels P Riksen
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Luuk B Hilbrands
- Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Rik G H Lindeboom
- Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, the Netherlands
| | - Joost H A Martens
- Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, the Netherlands
| | - Michiel Vermeulen
- Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, the Netherlands
| | - Leo A B Joosten
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Medical Genetics, University of Medicine and Pharmacy, Iuliu Haţieganu, Cluj-Napoca, Romania
| | - Mihai G Netea
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
| | - Willem J M Mulder
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands
| | - Johan van der Vlag
- Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands
| | - Abraham J P Teunissen
- Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Raphaël Duivenvoorden
- Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands; Biomolecular Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
| |
Collapse
|
4
|
Morla-Folch J, Vargas-Nadal G, Fuentes E, Illa-Tuset S, Köber M, Sissa C, Pujals S, Painelli A, Veciana J, Faraudo J, Belfield KD, Albertazzi L, Ventosa N. Ultrabright Föster Resonance Energy Transfer Nanovesicles: The Role of Dye Diffusion. Chem Mater 2022; 34:8517-8527. [PMID: 36248229 PMCID: PMC9558306 DOI: 10.1021/acs.chemmater.2c00384] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The development of contrast agents based on fluorescent nanoparticles with high brightness and stability is a key factor to improve the resolution and signal-to-noise ratio of current fluorescence imaging techniques. However, the design of bright fluorescent nanoparticles remains challenging due to fluorescence self-quenching at high concentrations. Developing bright nanoparticles showing FRET emission adds several advantages to the system, including an amplified Stokes shift, the possibility of ratiometric measurements, and of verifying the nanoparticle stability. Herein, we have developed Förster resonance energy transfer (FRET)-based nanovesicles at different dye loadings and investigated them through complementary experimental techniques, including conventional fluorescence spectroscopy and super-resolution microscopy supported by molecular dynamics calculations. We show that the optical properties can be modulated by dye loading at the nanoscopic level due to the dye's molecular diffusion in fluid-like membranes. This work shows the first proof of a FRET pair dye's dynamism in liquid-like membranes, resulting in optimized nanoprobes that are 120-fold brighter than QDot 605 and exhibit >80% FRET efficiency with vesicle-to-vesicle variations that are mostly below 10%.
Collapse
Affiliation(s)
- Judit Morla-Folch
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Guillem Vargas-Nadal
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Edgar Fuentes
- Nanoscopy
for Nanomedicine Group, Institute for Bioengineering
of Catalonia (IBEC) C\ Baldiri Reixac 15-21, Helix Building, Barcelona, 08028, Catalonia, Spain
| | - Sílvia Illa-Tuset
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
| | - Mariana Köber
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Cristina Sissa
- Dipartimento
di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, Parma, 43124, Italy
| | - Silvia Pujals
- Nanoscopy
for Nanomedicine Group, Institute for Bioengineering
of Catalonia (IBEC) C\ Baldiri Reixac 15-21, Helix Building, Barcelona, 08028, Catalonia, Spain
| | - Anna Painelli
- Dipartimento
di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, Parma, 43124, Italy
| | - Jaume Veciana
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| | - Jordi Faraudo
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
| | - Kevin D. Belfield
- Department
of Chemistry and Environmental Science, College of Science and Liberal
Arts, New Jersey Institute of Technology
(NJIT) 323 Martin Luther King, Jr., Blvd., Newark, New Jersey 07102, United States
| | - Lorenzo Albertazzi
- Nanoscopy
for Nanomedicine Group, Institute for Bioengineering
of Catalonia (IBEC) C\ Baldiri Reixac 15-21, Helix Building, Barcelona, 08028, Catalonia, Spain
- Molecular
Biosensing for Medical Diagnostics Group, Biomedical Engineering, Technology Eindhoven University of Technology (TUE) Eindhoven, 5612 AZ, The Netherlands
| | - Nora Ventosa
- Institut
de Ciència de Materials de Barcelona, ICMAB-CSIC, Campus UAB, Bellaterra, Catalonia 08193, Spain
- CIBER
de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)Instituto de Salud Carlos III. Bellaterra, 08193, Spain
| |
Collapse
|
5
|
Ballell-Hosa L, González-Mira E, Santana H, Morla-Folch J, Moreno-Masip M, Martínez-Prieto Y, Revuelta A, Di Mauro PP, Veciana J, Sala S, Ferrer-Tasies L, Ventosa N. DELOS Nanovesicles-Based Hydrogels: An Advanced Formulation for Topical Use. Pharmaceutics 2022; 14:pharmaceutics14010199. [PMID: 35057095 PMCID: PMC8779640 DOI: 10.3390/pharmaceutics14010199] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2021] [Revised: 01/10/2022] [Accepted: 01/12/2022] [Indexed: 11/20/2022] Open
Abstract
Topical delivery has received great attention due to its localized drug delivery, its patient compliance, and its low risk for side effects. Recent developments have focused on studying new drug delivery systems as a strategy for addressing the challenges of current topical treatments. Here we describe the advances on an innovative drug delivery platform called DELOS nanovesicles for topical drug delivery. Previously, the production of DELOS nanovesicles demonstrated potentiality for the topical treatment of complex wounds, achieving well-tolerated liquid dispersions by this route. Here, research efforts have been focused on designing these nanocarriers with the best skin tolerability to be applied even to damaged skin, and on exploring the feasibility of adapting the colloidal dispersions to a more suitable dosage form for topical application. Accordingly, these drug delivery systems have been efficiently evolved to a hydrogel using MethocelTM K4M, presenting proper stability and rheological properties. Further, the integrity of these nanocarriers when being gellified has been confirmed by cryo-transmission electron microscopy and by Förster resonance energy transfer analysis with fluorescent-labeled DELOS nanovesicles, which is a crucial characterization not widely reported in the literature. Additionally, in vitro experiments have shown that recombinant human Epidermal Growth Factor (rhEGF) protein integrated into gellified DELOS nanovesicles exhibits an enhanced bioactivity compared to the liquid form. Therefore, these studies suggest that such a drug delivery system is maintained unaltered when hydrogellified, becoming the DELOS nanovesicles-based hydrogels, an advanced formulation for topical use.
Collapse
Affiliation(s)
- Lídia Ballell-Hosa
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain; (L.B.-H.); (S.S.)
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Elisabet González-Mira
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Hector Santana
- Center for Genetic Engineering and Biotechnology (CIGB), 31st Avenue between 158 and 190 Streets, Cubanacán, Playa, Havana 10600, Cuba; (H.S.); (Y.M.-P.)
| | - Judit Morla-Folch
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Marc Moreno-Masip
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
| | - Yaima Martínez-Prieto
- Center for Genetic Engineering and Biotechnology (CIGB), 31st Avenue between 158 and 190 Streets, Cubanacán, Playa, Havana 10600, Cuba; (H.S.); (Y.M.-P.)
| | - Albert Revuelta
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
| | - Primiano Pio Di Mauro
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Jaume Veciana
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
| | - Santi Sala
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain; (L.B.-H.); (S.S.)
| | - Lidia Ferrer-Tasies
- Nanomol Technologies S.L., 08193 Cerdanyola del Vallès, Spain; (L.B.-H.); (S.S.)
- Correspondence: (L.F.-T.); (N.V.)
| | - Nora Ventosa
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), 08193 Bellaterra, Spain; (E.G.-M.); (J.M.-F.); (M.M.-M.); (A.R.); (P.P.D.M.); (J.V.)
- Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
- Correspondence: (L.F.-T.); (N.V.)
| |
Collapse
|
6
|
Morla-Folch J, Vargas-Nadal G, Zhao T, Sissa C, Ardizzone A, Kurhuzenkau S, Köber M, Uddin M, Painelli A, Veciana J, Belfield KD, Ventosa N. Dye-Loaded Quatsomes Exhibiting FRET as Nanoprobes for Bioimaging. ACS Appl Mater Interfaces 2020; 12:20253-20262. [PMID: 32268722 DOI: 10.1021/acsami.0c03040] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Fluorescent organic nanoparticles (FONs) are emerging as an attractive alternative to the well-established fluorescent inorganic nanoparticles or small organic dyes. Their proper design allows one to obtain biocompatible probes with superior brightness and high photostability, although usually affected by low colloidal stability. Herein, we present a type of FONs with outstanding photophysical and physicochemical properties in-line with the stringent requirements for biomedical applications. These FONs are based on quatsome (QS) nanovesicles containing a pair of fluorescent carbocyanine molecules that give rise to Förster resonance energy transfer (FRET). Structural homogeneity, high brightness, photostability, and high FRET efficiency make these FONs a promising class of optical bioprobes. Loaded QSs have been used for in vitro bioimaging, demonstrating the nanovesicle membrane integrity after cell internalization, and the possibility to monitor the intracellular vesicle fate. Taken together, the proposed QSs loaded with a FRET pair constitute a promising platform for bioimaging and theranostics.
Collapse
Affiliation(s)
- Judit Morla-Folch
- Institut Ciencia dels Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Cerdanyola, Spain
- Department of Chemistry and Environmental Science, College of Science and Liberal Arts, New Jersey Institute of Technology, 323 Martin Luther King, Jr., Blvd., Newark, New Jersey 07102, United States
| | - Guillem Vargas-Nadal
- Institut Ciencia dels Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Cerdanyola, Spain
| | - Tinghan Zhao
- Department of Chemistry and Environmental Science, College of Science and Liberal Arts, New Jersey Institute of Technology, 323 Martin Luther King, Jr., Blvd., Newark, New Jersey 07102, United States
| | - Cristina Sissa
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy
| | - Antonio Ardizzone
- Institut Ciencia dels Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Cerdanyola, Spain
| | - Siarhei Kurhuzenkau
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy
| | - Mariana Köber
- Institut Ciencia dels Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Cerdanyola, Spain
- Centro de Investigación Biomédica en Red CIBER-BBN, Barcelona, Spain
| | - Mehrun Uddin
- Department of Chemistry and Environmental Science, College of Science and Liberal Arts, New Jersey Institute of Technology, 323 Martin Luther King, Jr., Blvd., Newark, New Jersey 07102, United States
| | - Anna Painelli
- Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy
| | - Jaume Veciana
- Institut Ciencia dels Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Cerdanyola, Spain
- Centro de Investigación Biomédica en Red CIBER-BBN, Barcelona, Spain
| | - Kevin D Belfield
- Department of Chemistry and Environmental Science, College of Science and Liberal Arts, New Jersey Institute of Technology, 323 Martin Luther King, Jr., Blvd., Newark, New Jersey 07102, United States
| | - Nora Ventosa
- Institut Ciencia dels Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193 Cerdanyola, Spain
- Centro de Investigación Biomédica en Red CIBER-BBN, Barcelona, Spain
| |
Collapse
|
7
|
Morla-Folch J, Gisbert-Quilis P, Masetti M, Garcia-Rico E, Alvarez-Puebla RA, Guerrini L. Innentitelbild: Conformational SERS Classification of K-Ras
Point Mutations for Cancer Diagnostics (Angew. Chem. 9/2017). Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201700564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Judit Morla-Folch
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Patricia Gisbert-Quilis
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Matteo Masetti
- Department of Pharmacy and Biotechnology; Alma Mater Studiorum-Università di Bologna; via Belmeloro 6 40126 Bologna Italy
| | - Eduardo Garcia-Rico
- Department of Clinical Oncology; Hospital Univesitario; HM Torrelodones 28250 Madrid Spain
| | - Ramon A. Alvarez-Puebla
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- ICREA; Passeig Lluís Companys 23 08010 Barcelona Spain
| | | |
Collapse
|
8
|
Morla-Folch J, Gisbert-Quilis P, Masetti M, Garcia-Rico E, Alvarez-Puebla RA, Guerrini L. Inside Cover: Conformational SERS Classification of K-Ras
Point Mutations for Cancer Diagnostics (Angew. Chem. Int. Ed. 9/2017). Angew Chem Int Ed Engl 2017. [DOI: 10.1002/anie.201700564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Judit Morla-Folch
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Patricia Gisbert-Quilis
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Matteo Masetti
- Department of Pharmacy and Biotechnology; Alma Mater Studiorum-Università di Bologna; via Belmeloro 6 40126 Bologna Italy
| | - Eduardo Garcia-Rico
- Department of Clinical Oncology; Hospital Univesitario; HM Torrelodones 28250 Madrid Spain
| | - Ramon A. Alvarez-Puebla
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- ICREA; Passeig Lluís Companys 23 08010 Barcelona Spain
| | | |
Collapse
|
9
|
Morla-Folch J, Gisbert-Quilis P, Masetti M, Garcia-Rico E, Alvarez-Puebla RA, Guerrini L. Conformational SERS Classification of K-Ras
Point Mutations for Cancer Diagnostics. Angew Chem Int Ed Engl 2017; 56:2381-2385. [DOI: 10.1002/anie.201611243] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2016] [Revised: 12/12/2016] [Indexed: 12/13/2022]
Affiliation(s)
- Judit Morla-Folch
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Patricia Gisbert-Quilis
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Matteo Masetti
- Department of Pharmacy and Biotechnology; Alma Mater Studiorum-Università di Bologna; via Belmeloro 6 40126 Bologna Italy
| | - Eduardo Garcia-Rico
- Department of Clinical Oncology; Hospital Univesitario; HM Torrelodones 28250 Madrid Spain
| | - Ramon A. Alvarez-Puebla
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- ICREA; Passeig Lluís Companys 23 08010 Barcelona Spain
| | | |
Collapse
|
10
|
Morla-Folch J, Gisbert-Quilis P, Masetti M, Garcia-Rico E, Alvarez-Puebla RA, Guerrini L. Conformational SERS Classification of K-Ras
Point Mutations for Cancer Diagnostics. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201611243] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Judit Morla-Folch
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Patricia Gisbert-Quilis
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- Medcom Advance S.A.; Av. Roma 08840 Barcelona Spain
| | - Matteo Masetti
- Department of Pharmacy and Biotechnology; Alma Mater Studiorum-Università di Bologna; via Belmeloro 6 40126 Bologna Italy
| | - Eduardo Garcia-Rico
- Department of Clinical Oncology; Hospital Univesitario; HM Torrelodones 28250 Madrid Spain
| | - Ramon A. Alvarez-Puebla
- Deapartment of Physical Chemistry; Universitat Rovira i Virgili; Carrer de Marcellí Domingo s/n 43007 Tarragona Spain
- ICREA; Passeig Lluís Companys 23 08010 Barcelona Spain
| | | |
Collapse
|
11
|
Abstract
Design of ultrasensitive DNA sensors based on the unique physical properties of plasmonic nanostructures has become one of the most exciting areas in nanomedicine. However, despite the vast number of proposed applications, the determination of the base composition in nucleic acids, a fundamental parameter in genomic analyses and taxonomic classification, is still restricted to time-consuming and poorly sensitive conventional methods. Herein, we demonstrate the possibility of determining the base composition in single- and double-stranded DNA by using a simple, low-cost, high-throughput, and label-free surface-enhanced Raman scattering (SERS) method in combination with cationic nanoparticles.
Collapse
Affiliation(s)
- Judit Morla-Folch
- Medcom Advance , Viladecans Business Park, Edificio Brasil, Bertran i Musitu 83-85, 08840 Viladecans, Barcelona, Spain
- Centro Tecnológico de la Química de Catalunya and Universitat Rovira I Virgili , Carrer de Marcel•lí Domingo s/n, 43007 Tarragona, Spain
| | - Ramon A Alvarez-Puebla
- Medcom Advance , Viladecans Business Park, Edificio Brasil, Bertran i Musitu 83-85, 08840 Viladecans, Barcelona, Spain
- Centro Tecnológico de la Química de Catalunya and Universitat Rovira I Virgili , Carrer de Marcel•lí Domingo s/n, 43007 Tarragona, Spain
- ICREA , Passeig Lluís Companys 23, 08010 Barcelona, Spain
| | - Luca Guerrini
- Medcom Advance , Viladecans Business Park, Edificio Brasil, Bertran i Musitu 83-85, 08840 Viladecans, Barcelona, Spain
- Centro Tecnológico de la Química de Catalunya and Universitat Rovira I Virgili , Carrer de Marcel•lí Domingo s/n, 43007 Tarragona, Spain
| |
Collapse
|
12
|
Abstract
As more biological activities of ribonucleic acids continue to emerge, the development of efficient analytical tools for RNA identification and characterization is necessary to acquire an in-depth understanding of their functions and chemical properties. Herein, we demonstrate the capacity of label-free direct surface-enhanced Raman scattering (SERS) analysis to access highly specific structural information on RNAs at the ultrasensitive level. This includes the recognition of distinctive vibrational features of RNAs organized into a variety of conformations (micro-, fully complementary duplex-, small interfering- and short hairpin-RNAs) or characterized by subtle chemical differences (single-base variances, nucleobase modifications and backbone composition). This method represents a key advance in the ribonucleic acid analysis and will have a direct impact in a wide range of different fields, including medical diagnosis, drug design, and biotechnology, by enabling the rapid, high-throughput, simple, and low-cost identification and classification of structurally similar RNAs.
Collapse
Affiliation(s)
- Judit Morla-Folch
- Medcom Advance , Viladecans Business Park, Edificio Brasil, Bertran i Musitu 83-85, 08840 Viladecans, Barcelona, Spain
- Universitat Rovira i Virgili and Centro Tecnológico de la Química de Catalunya , Carrer de Marcel·lí Domingo s/n, 43007 Tarragona, Spain
| | - Hai-nan Xie
- Medcom Advance , Viladecans Business Park, Edificio Brasil, Bertran i Musitu 83-85, 08840 Viladecans, Barcelona, Spain
| | - Ramon A Alvarez-Puebla
- Medcom Advance , Viladecans Business Park, Edificio Brasil, Bertran i Musitu 83-85, 08840 Viladecans, Barcelona, Spain
- Universitat Rovira i Virgili and Centro Tecnológico de la Química de Catalunya , Carrer de Marcel·lí Domingo s/n, 43007 Tarragona, Spain
- ICREA , Passeig Lluís Companys 23, 08010 Barcelona, Spain
| | - Luca Guerrini
- Medcom Advance , Viladecans Business Park, Edificio Brasil, Bertran i Musitu 83-85, 08840 Viladecans, Barcelona, Spain
| |
Collapse
|
13
|
Morla-Folch J, Xie HN, Gisbert-Quilis P, Pedro SGD, Pazos-Perez N, Alvarez-Puebla RA, Guerrini L. Ultrasensitive Direct Quantification of Nucleobase Modifications in DNA by Surface-Enhanced Raman Scattering: The Case of Cytosine. Angew Chem Int Ed Engl 2015; 54:13650-4. [DOI: 10.1002/anie.201507682] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2015] [Revised: 09/06/2015] [Indexed: 12/23/2022]
|
14
|
Morla-Folch J, Xie HN, Gisbert-Quilis P, Pedro SGD, Pazos-Perez N, Alvarez-Puebla RA, Guerrini L. Ultrasensitive Direct Quantification of Nucleobase Modifications in DNA by Surface-Enhanced Raman Scattering: The Case of Cytosine. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201507682] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|